William Blair initiates Immunome stock coverage with outperform rating
Covered in this story
Analyst targets on Immunome Inc
- Stifel: $21.5 → $24 by Sep 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IMNM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Immunome Inc →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.